arrow
M

María-Jesús Pinazo

drugs for neglected diseases initiative
H指数:43
被引数:6,092

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Perspective on Biomarkers, Candidates for Surrogate End Points to Accelerate Successful Development of New Antiparasitic Agents for the Treatment of Chronic Chagas Disease

对生物标志物作为加速慢性恰加斯病治疗中新抗寄生虫药物成功开发的替代终点的候选者的展望

2026-01-010
PRE
New regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trial

苯唑硝唑的新治疗方案用于治疗成人慢性恰加斯病(indeterminate form或伴有轻度心脏进展)患者(NuestroBen研究):一项III期随机、多中心非劣效性临床试验的方案

2025-09-290
OAAI
Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: a secondary analysis of individual patient data from two proof-of-concept trials

量化抗锥虫治疗在慢性不确定型恰加斯病中的效果:一项来自两项概念验证试验的个体患者数据的二次分析

2025-09-090
OAAI
A guide for the generation of repositories of clinical samples for research on Chagas disease
2024-08-151
OAAI
A standardized clinical database for research in Chagas disease: The NHEPACHA network
2024-08-152
OAAI
Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial
2024-04-0115
PRE
Evaluation of the accuracy of a multi-infection screening test based on a multiplex immunoassay targeting imported diseases common in migrant populations
2024-01-011
OAAI
Five-year serological and clinical evolution of chronic Chagas disease patients in Cochabamba, Bolivia
2023-12-290
OAAI
Characterization of Latin American migrants at risk for Trypanosoma cruzi infection in a non-endemic setting. Insights into initial evaluation of cardiac and digestive involvement
2023-07-134
OAAI
Clinical profile and mortality in patients with T. cruzi/HIV co-infection from the multicenter data base of the Network for healthcare and study of Trypanosoma cruzi/HIV co-infection and other immunosuppression conditions (vol 15, e0009809, 2021)
2023-01-041
OAAI
A Branched and Double Alpha-Gal-Bearing Synthetic Neoglycoprotein as a Biomarker for Chagas Disease

一种带有分支和双 α-gal的合成新糖蛋白作为查加斯病的生物标志物

2022-09-053
OAAI